|
|
|
Volumn 20, Issue 8, 2011, Pages
|
|
Outcomes and costs associated with initial maintenance therapy with fluticasone propionate-salmeterol xinafoate 250 μg/50 μg combination versus tiotropium in commercially insured patients with COPD
|
|
Author keywords
Bronchodilator; Chronic obstructive pulmonary disease (COPD); Corticosteroid; Cost; Fluticasone salmeterol xinafoate; Pharmacoeconomics; Tiotro?pium
|
|
Indexed keywords
ANDROSTANE DERIVATIVE;
DRUG DERIVATIVE;
FLUTICASONE, SALMETEROL DRUG COMBINATION;
GLUCOCORTICOID;
SALBUTAMOL;
SCOPOLAMINE DERIVATIVE;
TIOTROPIUM BROMIDE;
ADULT;
AGED;
ARTICLE;
CHRONIC OBSTRUCTIVE LUNG DISEASE;
COHORT ANALYSIS;
DRUG COMBINATION;
DRUG COST;
ECONOMICS;
FEMALE;
HUMAN;
INSURANCE;
MALE;
MIDDLE AGED;
PHARMACOECONOMICS;
RETROSPECTIVE STUDY;
TREATMENT OUTCOME;
ADULT;
AGED;
AGED, 80 AND OVER;
ALBUTEROL;
ANDROSTADIENES;
COHORT STUDIES;
DRUG COMBINATIONS;
DRUG COSTS;
DRUG THERAPY, COMBINATION;
ECONOMICS, PHARMACEUTICAL;
FEMALE;
GLUCOCORTICOIDS;
HUMANS;
INSURANCE COVERAGE;
MALE;
MIDDLE AGED;
PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;
RETROSPECTIVE STUDIES;
SCOPOLAMINE DERIVATIVES;
TREATMENT OUTCOME;
|
|
EID: 80053319826
PISSN: 10623388
EISSN: None
Source Type: Trade Journal
DOI: None Document Type: Note |
|
Times cited : (5)
|
|
References (0)
|
